Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Carcinoma, Intraductal, Noninfiltrating 2Smoldering Multiple Myeloma 1Polyps 1Peripheral Nervous System Diseases 1Monoclonal Gammopathy of Undetermined Significance 1Malnutrition 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Dyspareunia 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms, Male 1Breast Carcinoma In Situ 1

Interventions

maltodextrin 1Psychiatric Rehabilitation 1Mental Status and Dementia Tests 1Fatty Acids, Omega-3 1Doxorubicin 1Docosahexaenoic Acids 1Cyproheptadine 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Amino Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Malnutrition × Fatty Acids, Omega-3 × Clear all
NCT01051154 2016-08-22

DHA-ALL

Coordinación de Investigación en Salud, Mexico

Phase 2 Completed
72 enrolled
LymphoidOther hematologic neoplasm

Malnutrition, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡